11 Citations (Scopus)

Abstract

Aims: Obesity, which is at epidemic proportions in the USA, is associated with a higher risk of several co-morbid diseases including, cardiovascular disease, cancer and sleep apnea. Weight loss and weight maintenance programmmes are difficult to sustain for long term. Mental health problems such as apathy may be a major factor in patients unsuccessful in adhering to weight loss programmes. We propose that treating apathy will result in better weight loss in obese patients. Methods: This was a randomized prospective pilot study. Obese patients (n = 101) were randomized in a 1:2:2 ratio to either (i) standard nutrition counselling; or (ii) the Department of Veterans Affairs weight loss programme called 'motivate obese veterans everywhere ' (MOVE); or (iii) methylphenidate treatment plus the MOVE programme together. The intervention was for 6 months (26 weeks). Results: For the within groups analysis, the absolute changes in weight (kg) are as follows, for MOVE (mean: -1.84; 95% confidence interval (CI): -4.56 to 0.87; p = 0.25), Methylphenidate (mean: -4.61; 95% CI: -7.90 to -1.33; p = 0.04), standard nutrition counselling (mean: -0.60; 95% CI: -2.59 to 1.39; p = 0.21), which indicates that although all three groups lost weight, only the methylphenidate group achieved statistical significance. The between group differences of the relative change in weight were not statistically different. The apathy evaluation score and the patient activation measure improved in all groups. Conclusion: Together these data suggest that treating apathy might be an important factor in the success of weight management programmes.

Original languageEnglish (US)
Pages (from-to)419-423
Number of pages5
JournalDiabetes, Obesity and Metabolism
Volume14
Issue number5
DOIs
StatePublished - May 2012

Fingerprint

Apathy
Veterans
Methylphenidate
Weights and Measures
Weight Reduction Programs
Confidence Intervals
Counseling
Weight Loss
Patient Participation
Sleep Apnea Syndromes
Mental Health
Cardiovascular Diseases
Obesity
Maintenance
Prospective Studies
Neoplasms

Keywords

  • Obesity therapy
  • Randomized trial
  • Weight loss therapy

ASJC Scopus subject areas

  • Internal Medicine
  • Endocrinology, Diabetes and Metabolism
  • Endocrinology

Cite this

Role of apathy in the effectiveness of weight management programmes. / Desouza, Cyrus V; Padala, P. R.; Haynatzki, Gleb; Anzures, P.; Demasi, C.; Shivaswamy, Vijay.

In: Diabetes, Obesity and Metabolism, Vol. 14, No. 5, 05.2012, p. 419-423.

Research output: Contribution to journalArticle

@article{37be133ba30049c5ae11ad89e838f468,
title = "Role of apathy in the effectiveness of weight management programmes",
abstract = "Aims: Obesity, which is at epidemic proportions in the USA, is associated with a higher risk of several co-morbid diseases including, cardiovascular disease, cancer and sleep apnea. Weight loss and weight maintenance programmmes are difficult to sustain for long term. Mental health problems such as apathy may be a major factor in patients unsuccessful in adhering to weight loss programmes. We propose that treating apathy will result in better weight loss in obese patients. Methods: This was a randomized prospective pilot study. Obese patients (n = 101) were randomized in a 1:2:2 ratio to either (i) standard nutrition counselling; or (ii) the Department of Veterans Affairs weight loss programme called 'motivate obese veterans everywhere ' (MOVE); or (iii) methylphenidate treatment plus the MOVE programme together. The intervention was for 6 months (26 weeks). Results: For the within groups analysis, the absolute changes in weight (kg) are as follows, for MOVE (mean: -1.84; 95{\%} confidence interval (CI): -4.56 to 0.87; p = 0.25), Methylphenidate (mean: -4.61; 95{\%} CI: -7.90 to -1.33; p = 0.04), standard nutrition counselling (mean: -0.60; 95{\%} CI: -2.59 to 1.39; p = 0.21), which indicates that although all three groups lost weight, only the methylphenidate group achieved statistical significance. The between group differences of the relative change in weight were not statistically different. The apathy evaluation score and the patient activation measure improved in all groups. Conclusion: Together these data suggest that treating apathy might be an important factor in the success of weight management programmes.",
keywords = "Obesity therapy, Randomized trial, Weight loss therapy",
author = "Desouza, {Cyrus V} and Padala, {P. R.} and Gleb Haynatzki and P. Anzures and C. Demasi and Vijay Shivaswamy",
year = "2012",
month = "5",
doi = "10.1111/j.1463-1326.2011.01544.x",
language = "English (US)",
volume = "14",
pages = "419--423",
journal = "Diabetes, Obesity and Metabolism",
issn = "1462-8902",
publisher = "Wiley-Blackwell",
number = "5",

}

TY - JOUR

T1 - Role of apathy in the effectiveness of weight management programmes

AU - Desouza, Cyrus V

AU - Padala, P. R.

AU - Haynatzki, Gleb

AU - Anzures, P.

AU - Demasi, C.

AU - Shivaswamy, Vijay

PY - 2012/5

Y1 - 2012/5

N2 - Aims: Obesity, which is at epidemic proportions in the USA, is associated with a higher risk of several co-morbid diseases including, cardiovascular disease, cancer and sleep apnea. Weight loss and weight maintenance programmmes are difficult to sustain for long term. Mental health problems such as apathy may be a major factor in patients unsuccessful in adhering to weight loss programmes. We propose that treating apathy will result in better weight loss in obese patients. Methods: This was a randomized prospective pilot study. Obese patients (n = 101) were randomized in a 1:2:2 ratio to either (i) standard nutrition counselling; or (ii) the Department of Veterans Affairs weight loss programme called 'motivate obese veterans everywhere ' (MOVE); or (iii) methylphenidate treatment plus the MOVE programme together. The intervention was for 6 months (26 weeks). Results: For the within groups analysis, the absolute changes in weight (kg) are as follows, for MOVE (mean: -1.84; 95% confidence interval (CI): -4.56 to 0.87; p = 0.25), Methylphenidate (mean: -4.61; 95% CI: -7.90 to -1.33; p = 0.04), standard nutrition counselling (mean: -0.60; 95% CI: -2.59 to 1.39; p = 0.21), which indicates that although all three groups lost weight, only the methylphenidate group achieved statistical significance. The between group differences of the relative change in weight were not statistically different. The apathy evaluation score and the patient activation measure improved in all groups. Conclusion: Together these data suggest that treating apathy might be an important factor in the success of weight management programmes.

AB - Aims: Obesity, which is at epidemic proportions in the USA, is associated with a higher risk of several co-morbid diseases including, cardiovascular disease, cancer and sleep apnea. Weight loss and weight maintenance programmmes are difficult to sustain for long term. Mental health problems such as apathy may be a major factor in patients unsuccessful in adhering to weight loss programmes. We propose that treating apathy will result in better weight loss in obese patients. Methods: This was a randomized prospective pilot study. Obese patients (n = 101) were randomized in a 1:2:2 ratio to either (i) standard nutrition counselling; or (ii) the Department of Veterans Affairs weight loss programme called 'motivate obese veterans everywhere ' (MOVE); or (iii) methylphenidate treatment plus the MOVE programme together. The intervention was for 6 months (26 weeks). Results: For the within groups analysis, the absolute changes in weight (kg) are as follows, for MOVE (mean: -1.84; 95% confidence interval (CI): -4.56 to 0.87; p = 0.25), Methylphenidate (mean: -4.61; 95% CI: -7.90 to -1.33; p = 0.04), standard nutrition counselling (mean: -0.60; 95% CI: -2.59 to 1.39; p = 0.21), which indicates that although all three groups lost weight, only the methylphenidate group achieved statistical significance. The between group differences of the relative change in weight were not statistically different. The apathy evaluation score and the patient activation measure improved in all groups. Conclusion: Together these data suggest that treating apathy might be an important factor in the success of weight management programmes.

KW - Obesity therapy

KW - Randomized trial

KW - Weight loss therapy

UR - http://www.scopus.com/inward/record.url?scp=84859441898&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84859441898&partnerID=8YFLogxK

U2 - 10.1111/j.1463-1326.2011.01544.x

DO - 10.1111/j.1463-1326.2011.01544.x

M3 - Article

C2 - 22145671

AN - SCOPUS:84859441898

VL - 14

SP - 419

EP - 423

JO - Diabetes, Obesity and Metabolism

JF - Diabetes, Obesity and Metabolism

SN - 1462-8902

IS - 5

ER -